J&J Manufacturing Woes Lead To Recall Of Children's Tylenol In Korea
This article was originally published in PharmAsia News
Johnson & Johnson's Janssen subsidiary ordered a recall of all 1.7 million bottles of its Children's Tylenol syrup produced and sold in South Korea, citing excessive levels of acetaminophen, which could cause liver damage.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.